Privia Health Group, Inc. (NASDAQ:PRVA) Stock Now Rated “Moderate Buy” by Wall Street Brokerages

Shares of Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ten analysts that are covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $31.30.

A number of analysts recently commented on the company. Citigroup reiterated a “buy” rating on shares of Privia Health Group in a report on Thursday, July 23rd. Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Wednesday, August 5th. Piper Sandler increased their target price on Privia Health Group from $36.00 to $38.00 and gave the company an “overweight” rating in a research note on Friday, November 6th. Canaccord Genuity Group raised their price target on Privia Health Group from $32.00 to $33.00 and gave the stock a “buy” rating in a research report on Friday, November 6th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Privia Health Group in a report on Tuesday, September 29th.

View Our Latest Research Report on Privia Health Group

Institutional Trading of Privia Health Group

Institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. bought a new stake in shares of Privia Health Group in the second quarter worth approximately $550,684,000. Durable Capital Partners LP boosted its position in shares of Privia Health Group by 2.9% during the 3rd quarter. Durable Capital Partners LP now owns 11,970,968 shares of the company’s stock valued at $235,708,000 after acquiring an additional 335,020 shares during the last quarter. Rubicon Founders LLC bought a new stake in shares of Privia Health Group in the 2nd quarter valued at approximately $153,635,863. Van Berkom & Associates Inc. boosted its stake in shares of Privia Health Group by 5.4% during the 1st quarter. Van Berkom & Associates Inc. now owns 4,053,043 shares of the company’s stock worth $83,371,000 after purchasing an additional 208,787 shares during the period. Finally, Bank of New York Mellon Corp bought a new stake in shares of Privia Health Group during the 2nd quarter worth approximately $74,425,000. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Privia Health Group Stock Performance

Shares of PRVA stock opened at $24.69 on Friday. Privia Health Group has a fifty-two week low of $18.92 and a fifty-two week high of $28.82. The company has a market cap of $3.15 billion, a P/E ratio of 94.97 and a beta of 0.76. The stock has a 50 day simple moving average of $21.75 and a two-hundred day simple moving average of $22.69.

Privia Health Group (NASDAQ:PRVA – Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.12. The business had revenue of $656.96 million for the quarter, compared to analyst estimates of $610.72 million. Privia Health Group had a return on equity of 4.20% and a net margin of 1.43%. The company’s quarterly revenue was up 13.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.29 earnings per share. On average, research analysts predict that Privia Health Group will post 0.29 earnings per share for the current year.

Privia Health Group Company Profile

(Get Free Report)

Privia Health Group, Inc. is a physician enablement company that partners with independent medical groups, health systems and other providers. Its technology-enabled platform is designed to help physicians manage their practices and deliver coordinated care, while retaining their clinical independence. The company provides practice management, technology, care coordination and population health services. It also helps providers participate in value-based care arrangements, which tie payments more closely to the quality and efficiency of care.

Recommended Stories

Analyst Recommendations for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.